𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Levodopa therapy for Parkinson's disease: Challenges and future prospects

✍ Scribed by C. Warren Olanow; Andrew Lees; Jose Obeso

Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
38 KB
Volume
23
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Physical therapy in Parkinson's disease:
Physical therapy in Parkinson's disease: Evolution and future challenges
✍ Samyra H.J. Keus; Marten Munneke; Maarten J. Nijkrake; Gert Kwakkel; Bastiaan R. πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 196 KB

## Abstract Even with optimal medical management using drugs or neurosurgery, patients with Parkinson's disease (PD) are faced with progressively increasing mobility problems. For this reason, many patients require additional physical therapy. Here, we review the professional evolution and scientif

Dopaminergic transplantation for parkins
Dopaminergic transplantation for parkinson's disease: Current status and future prospects
✍ C. Warren Olanow; Jeffrey H. Kordower; Anthony E. Lang; Jose A. Obeso πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 258 KB πŸ‘ 2 views

## Abstract Cell‐based therapies that involve transplantation into the striatum of dopaminergic cells have attracted considerable interest as possible treatments for Parkinson's disease (PD). However, all double‐blind, sham‐controlled, studies have failed to meet their primary endpoints, and transp

Parkinson's disease/Parkinson syndromesβ€”
Parkinson's disease/Parkinson syndromesβ€”therapy: Levodopa
πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 249 KB

Three patients with Parlcinson's disease, optimally treated with levodopdcabidopa (LDKD) tablets, but experiencing severe motor fluctuations, were administered a solution of levodopd carbidopalascorbic acid (LCAS) orally at intervals ranging from 30 to 60 minutes. Patients were rated half-hourly to